Summary
This is a report on 14 patients receiving vindesine continuously for between 1 and 7 years. Total vindesine doses ranged from 86 mg to 454 mg and the longest treatment duration was 2564 days. Although there was no patient without a transient acute or subacute toxicity, no unequivocal signs of long-term toxicity have been observed so far. Greater caution must be given to the concomitant use of higher radiation doses and vindesine, since local reactions were more pronounced especially at the lung. The drug seems to be tolerated for longer periods without major or cumulative toxicity, which makes it suitable for use in the adjuvant setting, for instance, or within an antimetastatic approach.
Similar content being viewed by others
References
Atassi G, Dumont P, Vandendris M (1982) Investigation of the in vivo anti-invasive and anti-metastatic effect of desacetyl vinblastine amide sulphate or vindesine. Invasion Metastasis 2:217–231
Dyke RW, Nelson RL (1977) Phase I anti-cancer agents, vindesine. Cancer Treat Rev 4:135–142
Huntington MO (1985) Weight gain in patients receiving adjuvant chemotherapy for carcinoma of the breast. Cancer 56:472–474
Knobf MK, Mullen JC, Xistris D, Moritz DA (1983) Weight gain in women with breast cancer receiving adjuvant chemotherapy. Oncol Nursing Forum 10:28–33
Mareel MM, De Mets W (1984) Effect of microtubule inhibitors on invasion and related activities of tumor cells. Int Rev Cytol 90:125–168
Rhomberg WU (1986) Vindesine for recurrent and metastatic cancer of the uterine cervix, a phase II study. Cancer Treat Rep 10:1455–1457
Storme G, Schallier D, De Neve W, De Greve J, Van Belle S, Dewasch G, Dotremont G (1985) In: Hellmann K, Eccles SA (eds) Prevention of metastasis, problems and prospects, Taylor & Francis, London, pp 25–28
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rhomberg, W., Eiter, H., Soltesz, E. et al. Long-term application of vindesine: toxicity and tolerance. J Cancer Res Clin Oncol 116, 651–653 (1990). https://doi.org/10.1007/BF01637089
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01637089